Groupe Rocher aims to fundamentally transform how it designs its future cosmetic formulations. The goal is to save time in research and development while strengthening the capacity to test, compare, and optimize ingredients even before laboratory trials.
Digital twins to simulate skin
At the core of this new industrial setup, Dassault Systèmes brings its simulation technologies, 3D modelling capabilities, and generative artificial intelligence. The idea is to use digital twins to reproduce, in a digital format, the interactions between active ingredients and the skin. The Rocher Group hopes to explore more avenues upstream, with fewer back-and-forths in the lab.
For the Brittany-based group, this approach should enable faster identification of the most promising combinations, better anticipation of results, and a clearer direction for its research teams toward the most relevant formulations.
Groupe Rocher estimates that today it takes, on average, about thirty trials to reach a satisfactory formulation. With this new tool, the ambition is to shorten development timelines by roughly 20% and speed up the transition from concept to finished product.
Beyond productivity, the aim is to better control product quality from the early design stages. By leaning more on simulation, researchers can focus their resources on the most credible formulations, rather than multiplying exploratory tests that are costly in time and resources.
Reducing time to market
After aerospace, automotive, and heavy industry, cosmetics is now embracing the logic of digital twins as well.
For Dassault Systèmes, the agreement signals that its tools are no longer confined to mechanical engineering but can also become accelerators of research in specialized scientific fields.
In the longer term, this type of collaboration could redefine how major brands conceive their product ranges.
